Xspray Pharma: Support from principal owners - Redeye

Redeye considers the declaration of intents for the TO6 warrants from Xspray's largest shareholders to be very supportive news, especially considering that the company stands before a PDUFA date and potential US approval for Dasynoc at the end of July.

Länk till analysen i sin helhet: https://www.redeye.se/research/996421/xspray-pharma-support-from-principal-owners?utm_source=finwire&utm_medium=RSS